Trailhead Biosystems Competitors and Similar CompaniesClear all
Trailhead Biosystems's competitors and similar companies include Palatin Technologies, Acticor Biotech and Albumedix.
 Palatin Technologies Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases. |  Acticor Biotech Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke. |  Albumedix Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 1986 | Founding Date 2013 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Cleveland, US HQ | Locations East Windsor, US HQ | Locations Paris, FR HQ Paris, FR | Locations Nottinghamshire, GB HQ Nottingham, GB |
Employees | Employees 462% increase | Employees 185% decrease | Employees 1711% decrease | Employees 871% increase |
Financial | ||||
Net income | Net income N/A | Net income ($17.3m) (FY, 2025) | Net income N/A | Net income £5m (FY, 2018) |
Funding | ||||
Latest funding round | Latest funding round $ 6.6m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 7.8m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 6.7m | Total funding raised $ 104.2m | Total funding raised $ 33.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Palatin Technologies
HQ
East Windsor, US
Employees
18↓ 5% decrease
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
View companyActicor Biotech
HQ
Paris, FR
Employees
17↓ 11% decrease
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
View companyAlbumedix
HQ
Nottinghamshire, GB
Employees
87↑ 1% increase
Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases.
View company